Orthofix names DePuy, Medtronic, Biomet veteran the next CEO

Laura Dyrda -   Print  | Email

Orthofix named Jon Serbousek president of global spine on an interim basis before he replaces the retiring Brad Mason as CEO of the company on Nov. 1.

Mr. Serbousek has more than 30 years of experience in the medical device and biotech industries, including 13 years with DePuy Orthopedics, a Johnson & Johnson company. He eventually became vice president of spinal operations at DePuy Orthopedics. He also had experience as Medtronic's worldwide president of spine and president of Biomet's U.S. orthopedics.

"Jon's expertise and proven track record are perfectly aligned with our business composition and make him an exceptional choice to lead the company as president and CEO," said Mr. Mason. "With the recent leadership change in our spine business, I am pleased that Jon has agreed to serve as president of global spine on an interim basis. This will give him time to focus on our needs and opportunities in that business before he takes on the broader CEO role, which should help ensure a seamless leadership transition for the benefit of the Orthofix shareholders."

Mr. Serbousek received restricted stock units of around 14,743 shares of Orthofix common stock after becoming employed by Orthofix. He also has the option to purchase an additional 50,711 shares of Orthofix common stock.

More articles on orthopedic devices:
RTI Surgical posts $82.3M in Q2 revenue: 6 things to know
Alphatec prices public offering to raise $50M: 4 details
SeaSpine launches implant platform for revision spinal fusion

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.